Swiss pharma bids $43.7B for remaining shares of biotech firm
(Newser) -
Swiss pharmaceutical company Roche today offered $43.7 billion for the outstanding shares of Genentech, the San Francisco-based biotech firm in which Roche already owns a 55.9% stake, the
Wall Street Journal reports. The $89-a-share offer is the latest in a series of big pharma companies, whose new drug...
More »
